Web Industries names replacement for retiring CEO
15 Dec 2022
Executive Change
Web Industries today announced John Madej as the contract manufacturing organization’s next CEO.
Madej joined Web Industries as president in March 2022 after 13 years with Hollingsworth & Vose, where he was COO and CFO. He also spent 24 years at General Electric in the U.S. and Japan, serving as president and CEO for Exatec LLC, a GE-Bayer joint venture.
Madej will replace retiring CEO Mark Pihl, who will now chair the employee-owned company’s board.
“The focus on building and maintaining trusted relationships has a strong history and emphasis at Web Industries,” Madej said in a news release. “I’m looking forward to using this strength to establish and nurture close collaborative relationships with customers.”
Marlborough, Massachusetts-based Web Industries offers precision converting and outsourced manufacturing services and has more than 700 employees.
“I’m very much looking forward to my new role and helping John execute on our vision for the company,” Pihl said in the release. “His successful track record across multiple industries will be invaluable in moving Web Industries toward our growth goals. As an employee-owned company, John’s inspirational leadership and proven strategic skills were very attractive to us. We’re all very impressed with the progress our business teams are already making under his direction.”
The company said its recent high-profile medtech work included helping scale global diagnostics production capabilities during the pandemic.
“Web Industries has a successful history of global growth across some of today’s most attractive market sectors,” Madej says. “Our people are experienced, innovative, and dedicated, and I look forward to putting these advantages to work for our customers to improve their productivity, performance and profitability. At a time when supply-chain challenges are intense, Web Industries has all the right capabilities and expertise, and a reputation for a high degree of collaboration with our partners.”
RELATED: The biggest medtech personnel moves in 2022
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.